Ozempic has a superuser.
The latest: FAIR Health data shows women 40–64 are the top recipients of GLP-1 prescriptions, with 18.6% using them for weight loss, double the rate of men.
Beyond weight. Off-label use is rising as women seek agency over midlife health. In particular, hormone therapy is being paired with GLP-1s for menopause support. Under review, GLP-1s are also being explored for conditions like PCOS as well.
Whole picture. But, lifestyle medicine is on the rise in tandem. Linked to longevity, women 40+ are turning to strength training, rucking, high-protein diets, creatine, and wellness retreats from Equinox and Canyon Ranch to preserve muscle and manage symptoms.
Takeaway: GLP-1s offer promise but aren’t a silver bullet. For midlife women, sustainable progress points to holistic, personalized approaches over one-size-fits-all solutions.
